neobookRx
DrugsLevel 4 LocalisationS4OPDEML

Oxybuprocaine

Sodium channel blockerLocal anaesthetic

Indications

Registered South African indications:

  • Ophthalmic pain

Cautions

Contraindications

  • Hypersensitivity to the active ingredient or any of its excipients

Cautions

  • Pregnancy
  • Breastfeeding
  • Renal impairment
  • Hepatic impairment

Adult dosage

Forms avail. in SA and covered in this monograph: opd

Ophthalmic pain

  • Ophthalmic (opd): 1-3 drops into affected eye(s), administered at 90 second intervals

Paediatric dosage

See adult dosage

Special populations

Pregnancy

  • Caution
  • Oxybuprocaine should not be used in pregnancy unless the benefits clearly outweigh the possible risks to the mother and foetus

Breastfeeding

  • Caution
  • Oxybuprocaine should not be used by breastfeeding mothers unless the benefits clearly outweigh the possible risks to the mother and infant

Renal Impairment

Hepatic Impairment

Elderly

Porphyria Information

Drugs in Sport

  • Permitted - No warnings

Adverse reactions

Sensory Disorders

  • Transient stinging 
  • Blurring of vision
  • Corneal damage

Interactions

No information available

Monitoring

None routine

Mechanism of action

Oxybuprocaine hydrochloride is used as a local anaesthetic. It reversibly blocks the propagation and conduction of nerve impulses along nerve axons.

Dosage forms

  • Eye drops

Formulation

Eye drop (per 100ml) 0.4g

  • Novesin Wander 0.4% (Adcock) originator
  • Minims Oxybuprocaine hcl 0.4% (was Min benoxinate hcl) (Soflens) originator

References

1. SAMF_12th Edition_Page 584 2. SmPC: Minims Oxybuprocaine Hydrochloride 0.4% w/v, Bausch & Lomb U.K Limited: Last updated on eMC: 16 Jul 2012; Downloaded online 16 Aug 2018 [https://www.medicines.org.uk/emc/medicine/417 ] 3. https://drive.google.com/drive/folders/0B27NqM_vidrmV0VrcGJCeHAtVXc (26/08/1970_Soflens_Minims Oxybuprocaine Hydrochloride 0.4%_eye drops) 4. NAPOS The Drug Database for Acute Porphyria: S01HA02 Oxybuprocaine; Accessed online 10 Feb 2019 [http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?atc_code=S01HA02&l=gbr] 5. South African Institute for Drug-Free Sport: Novesin Wander; Accessed online 10 Feb 2019 [http://www.drugfreesport.org.za/online-medication-check/]

Brands & products

2 products · stale NAPPI snapshot · refreshed 5/28/2026 · 159 days old

OpmGeneric· 1 product

from R29.80/unit
ProductStrengthPackSchedSEPUnitDisp feeNAPPI
Min oxybuprocaine hcl (was Min benoxinat- g/100ml0S4R595.94R29.80R172.13743526015

dropsGeneric· 1 product

from R89.27/unit
ProductStrengthPackSchedSEPUnitDisp feeNAPPI
Novesin wander 3ml- g/100ml3S4R267.81R89.27R98.88748188002
Trade names (2)
  • Novesin Wander 0.4%
  • Minims Oxybuprocaine hcl 0.4% (was Min benoxinate hcl)

Medical aid coverage

data not yet integrated
Discovery Health
not yet integrated
  • Comprehensive Series—
  • Executive Plan—
  • KeyCare Series—
  • Priority Series—
  • Saver Series—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Bonitas Medical Fund
not yet integrated
  • BonClassic—
  • BonComprehensive—
  • BonEssential—
  • BonFit Select—
  • BonSave—
  • BonStart—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

GEMS — Government Employees Medical Scheme
not yet integrated
  • Beryl—
  • Emerald—
  • Onyx—
  • Ruby—
  • Sapphire—
  • Tanzanite One—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

POLMED — Police Medical Aid Scheme
not yet integrated
  • Aquarium Option—
  • Efficiency Option—
  • Marine Option—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Cited in 3 documents

NeoHealth® ID 16047 · updated 11/1/2022